May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Saadvik Raghuram Y: A Randomized Trial of Afatinib vs Chemotherapy in NSCLC
May 26, 2025, 18:47

Saadvik Raghuram Y: A Randomized Trial of Afatinib vs Chemotherapy in NSCLC

Saadvik Raghuram Y, Head of Department of Medical Oncology at Arete Hospitals, shared a post on X:

“Now a randomized trial of Afatinib vs Chemotherapy in NSCLC With Uncommon Activating EGFR Mutations
  • Exclusions: T790M; Exon 20 insertions
  • mPFS 10.6 vs 5.7 mo favoring AFATINIB
  • ORR 62% vs 56% favouring AFATINIB.”

Read further.

More posts featuring Saadvik Raghuram Y.